is mounjaro a glp 1 medication Understanding Mounjaro: Guide for Type 2 Diabetes Patients 🧬 New research presented at

As a result, this approach works best when combined with lifestyle changes like diet and physical activity

doi: 10.1289/ehp.106-1533202

Effective management of nausea and other gastrointestinal side effects can significantly improve treatment adherence and outcomes

Inadequate protein leads to muscle loss, metabolic slowdown, and increased likelihood of weight regain after stopping the medication

Results of randomized trials Six large randomized trials and a post hoc analysis 1521 have investigated the safety and efficacy of GLP-1 receptor agonists in patients with type 2 diabetes who also either had known cardiovascular disease or were at high risk of it, using a composite of major adverse cardiovascular events (myocardial infarction, stroke, or death from cardiovascular causes) as the primary end point (Table 2)

In type 2 diabetes, these hormones are greatly decreased and do not work as well to cause that insulin secretion